The University of Chicago Header Logo

Adalimumab: efficacy and safety in psoriasis and rheumatoid arthritis.

Adalimumab: efficacy and safety in psoriasis and rheumatoid arthritis. Dermatol Ther. 2004; 17(5):427-31.

View in: PubMed